Min Cong Huang
Directeur/Bestuurslid bij Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Oorsprong van het eerstegraads netwerk van Min Cong Huang
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008.
9
| Subsidiary | Pharmaceuticals: Major | 9 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Min Cong Huang via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
SIRNAOMICS LTD. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
Sirnaomics, Inc.
Sirnaomics, Inc. Pharmaceuticals: MajorHealth Technology Sirnaomics, Inc. develops novel targeted therapeutics for critical human diseases. It discovers and develops RNAi therapeutics. The firm pursues its proprietary technologies using pluripotent siRNA cocktail design and nanoparticle-enhanced therapeutic delivery to treat critical human diseases. The company was founded by Patrick Y. Lu, George Ji and David M. Evans in 2007 and is headquartered in Gaithersburg, MD. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
AGTECH HOLDINGS LIMITED | Wholesale Distributors | Director/Board Member | |
The Hong Kong University of Science & Technology | College/University | Corporate Officer/Principal | |
Stanford University | College/University | Corporate Officer/Principal | |
The Stock Exchange of Hong Kong Ltd.
The Stock Exchange of Hong Kong Ltd. Investment Banks/BrokersFinance HKEx is the holding company of The Stock Exchange of Hong Kong Limited, Hong Kong Futures Exchange Limited and Hong Kong Securities Clearing Company Limited. It brings together the market organisations which have transformed Hong Kong's financial services industry from a domestically focused market to become a central market place in Asia attracting investment funds from all over the world. HKEx was listed in June 2000 following the integration of Hong Kong's securities and derivatives markets. As a market-driven organisation, answerable to its shareholders, HKEx competes vigorously for opportunities in the region and around the world. HKEx's operations are organised into focused units, directly supervised and controlled by management and the board of directors. The board, the highest decision-making body, determines HKEx's objectives, missions, strategies, policies and business plan and monitors their implementation by management. In its role as the operator and frontline regulator of the central securities and derivatives marketplace in Hong Kong, HKEx regulates listed issuers; administers listing, trading and clearing rules; and provides services, primarily at the wholesale level, to customers of the exchanges and clearing houses, including issuers and intermediaries - investment banks or sponsors, securities and derivatives brokers, custodian banks and information vendors - who service the investor directly. These services comprise trading, clearing and settlement, depository and nominee services, and information services. | Investment Banks/Brokers | Corporate Officer/Principal | |
YNBY INTERNATIONAL LIMITED | Investment Banks/Brokers | Director/Board Member | |
Beijing Society For Neuroscience | Director/Board Member | ||
Taide Pharmaceutical (Zhejiang) Co., Ltd.
Taide Pharmaceutical (Zhejiang) Co., Ltd. BiotechnologyHealth Technology Medtide, Inc. is a peptide focused contract research, development and manufacturing organization. It services include contract research organization services, namely peptide new chemical entity discovery synthesis, contract development and manufacturing organization services, namely peptide chemistry, manufacturing and controls development, and contract manufacturing organization services, namely peptide NCE and generic drug commercial manufacturing. The company was founded by Li Xiang and Xu Qi on June 11, 2020 and is headquartered in Shaoxing, China. | Biotechnology | Director/Board Member | |
Chinese Neuroscience Society | Director/Board Member | ||
Dna-Tech Ltd. | Director/Board Member | ||
Angenomics Ltd. | Director/Board Member | ||
Hong Kong Dna Chips Ltd. | Founder | ||
Sun Yat-Sen Cultural Foundation Ltd. | Director/Board Member | ||
Hong Kong-Taiwan Youth Exchange Promotion Association Ltd. | Director/Board Member | ||
The Hong Kong Chinese Importers' & Exporters' Association | Director/Board Member | ||
Peking University Health Science Center | College/University | Corporate Officer/Principal | |
University of Prince Edward Island | College/University | Undergraduate Degree | |
The Passavant Memorial Area Hospital Association
The Passavant Memorial Area Hospital Association Medical/Nursing ServicesHealth Services The Passavant Memorial Area Hospital Association provides health care services. Its services include surgery, behavioral health, cardiac, laboratory, wound care, telehealth, and rehabilitation. The company was founded in 1875 and is headquartered in Jacksonville, IL. | Medical/Nursing Services | Corporate Officer/Principal | |
Chinese Academy of Sciences | College/University | Graduate Degree | |
Xiangxi Holley Pharmaceutical Co., Ltd.
Xiangxi Holley Pharmaceutical Co., Ltd. Pharmaceuticals: OtherHealth Technology Xiangxi Holley Pharmaceutical Co., Ltd. engages in the production and sale of artemisinin, medicine and pharmaceutical intermediates. It also engages in the planting, processing and sale of Chinese herbal medicine. The company was founded on June 8, 2001 and is headquartered in Jishou, China. | Pharmaceuticals: Other | Director/Board Member | |
Chongqing Holley Wulingshan Pharmaceutical Co. Ltd.
Chongqing Holley Wulingshan Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Holley Wulingshan Pharmaceutical Co. Ltd. manufactures drugs. Its products include artemisinin, artemether, dihydroartemisinin, saponin, Hydrolysate , artesunate, MQZK cough syrup, protein & tannic acid, protein tablets and other related drugs. The company was founded on December 24, 1986 and is headquartered in Chongqing, China. | Pharmaceuticals: Major | Director/Board Member | |
Beijing Holley Ketai Pharmaceutical Co., Ltd.
Beijing Holley Ketai Pharmaceutical Co., Ltd. Medical DistributorsDistribution Services Beijing Holley Ketai Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of pharmaceutical products. Its products include Chinese medicines, chemical medicines and chemical raw materials. It also provides export and import of goods and technical equipment related to medical. The company was founded on August 1, 1985 and is headquartered in Beijing, China. | Medical Distributors | Director/Board Member | |
KPC PHARMACEUTICALS,INC | Pharmaceuticals: Major | President | |
Genben Lifesciences Corp.
Genben Lifesciences Corp. BiotechnologyHealth Technology Genben Lifesciences Corp. engages in other health care industry group. The company is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Doctorate Degree | |
Yunnan Normal University | College/University | Undergraduate Degree | |
KEEN VISION ACQUISITION CORPORATION | Financial Conglomerates | Director/Board Member | |
Kunyao Group Co., Ltd | President | ||
Kunming Baker Norton Pharmaceutical Co. Ltd.
Kunming Baker Norton Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of KPC Pharmaceuticals, Inc., Kunming Baker Norton Pharmaceutical Co. Ltd. is a company that manufactures and distributes pharmaceutical products. The company is based in Kunming, China. Kunming Baker Norton Pharmaceutical Co. was acquired by KPC Pharmaceuticals, Inc. on November 16, 2015 for $47.35 million. | Pharmaceuticals: Major | Chief Executive Officer | |
WALVAX BIOTECHNOLOGY CO., LTD. | Biotechnology | Chairman | |
Trinity Power Ltd.
Trinity Power Ltd. Electric UtilitiesUtilities Trinity Power Ltd. operates as a natural gas fired power generation facility. It is responsible for generation of electrical power to the national electrical grid. The company is headquartered in Couva, Trinidad and Tobago. | Electric Utilities | Director/Board Member | |
Macrocure Ltd. (United States) | Chief Tech/Sci/R&D Officer | ||
Washington University in St. Louis | College/University | Graduate Degree | |
Dalhousie University | College/University | Doctorate Degree | |
Guangdong-Hong Kong-Macao Greater Bay Area Biotechnology Allia | Founder | ||
University of Saskatchewan | College/University | Doctorate Degree | |
Tiger Jade Acquisition Co.
Tiger Jade Acquisition Co. Financial ConglomeratesFinance Tiger Jade Acquisition Co. is a blank check company. It engages in the business of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on January 5, 2022 and is headquartered in Hong Kong. | Financial Conglomerates | Director/Board Member | |
CLSA Ltd.
CLSA Ltd. Investment Banks/BrokersFinance CLSA Ltd. is the Hong Kong-based institutional brokerage subsidiary of CITIC Securities Co., Ltd. (SSE: 600030, SEHK: 6030), a full-service investment bank headquartered in China. Founded in 1986, the firm provides sales and execution services to global investors and corporates. | Investment Banks/Brokers | Corporate Officer/Principal | |
FERRETTI S.P.A. | Recreational Products | Director/Board Member | |
CHEMPARTNER PHARMATECH CO.,LTD. | Miscellaneous Commercial Services | Chief Executive Officer | |
Cfs Global Resources Co. Ltd. | Director/Board Member | ||
BOCOM INTERNATIONAL HOLDINGS COMPANY LIMITED | Investment Banks/Brokers | Corporate Officer/Principal | |
Hebei Titans Medical Supply Technology Group Co. Ltd.
Hebei Titans Medical Supply Technology Group Co. Ltd. Medical SpecialtiesHealth Technology Hebei Titans Medical Supply Technology Group Co. Ltd. engages in the manufacture of personal hand protection products. Its products are disposable nitrile gloves and disposable vinyl gloves, which are widely used in medical care, clinical examination, chemical industry, electronics, food processing and other industries. The company was founded by Wen Xin Lu and Wei Dong Liu on February 23, 2011 and is headquartered in Xingtai, China. | Medical Specialties | Director/Board Member | |
BioSyngen Pte Ltd.
BioSyngen Pte Ltd. Pharmaceuticals: MajorHealth Technology BioSyngen Pte Ltd. focuses on the clinical and commercial transfer of immune-cell therapy technologies and products. The company was founded in 2016 and is headquartered in Singapore. | Pharmaceuticals: Major | Chairman | |
VIVA BIOTECH HOLDINGS | Biotechnology | Founder | |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member | |
Bank of America, NA (Charlotte, North Carolina)
Bank of America, NA (Charlotte, North Carolina) Major BanksFinance Bank of America, NA engages in the provision of commercial banking services. It offers financing, checking and savings accounts, and investment banking for individual clients. The company was founded on March 1, 1927 and is headquartered in Charlotte, NC. | Major Banks | Corporate Officer/Principal | |
ICEA Capital Ltd.
ICEA Capital Ltd. Regional BanksFinance Part of Industrial & Commercial Bank of China Ltd., ICEA Capital Ltd. provides banking services. The company is based in Hong Kong, Hong Kong. | Regional Banks | Corporate Officer/Principal |
Statistieken
Internationaal
China | 18 |
Hongkong | 16 |
Verenigde Staten | 10 |
Canada | 4 |
Bermuda | 2 |
Sectoraal
Health Technology | 14 |
Consumer Services | 11 |
Finance | 9 |
Distribution Services | 3 |
Health Services | 2 |
Operationeel
Director/Board Member | 46 |
Independent Dir/Board Member | 16 |
Corporate Officer/Principal | 14 |
Chairman | 13 |
Founder | 13 |
Sterkste connecties
Insiders | |
---|---|
Cheung Hoi Yu | 29 |
Feng Mao Hua | 23 |
Xiao Chang Dai | 15 |
Michael Vance Molyneaux | 7 |
Patrick Lu | 6 |
David Evans | 6 |
Jian Kang Zhang | 1 |
Meng Ying Huang | 1 |
Mu Xian Sheng | 1 |
- Beurs
- Insiders
- Min Cong Huang
- Bedrijfsconnecties